Download PDF
Thromb Haemost 1965; 14(03/04): 545-561
DOI: 10.1055/s-0038-1654889
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Determination of Plasminogen in Human Plasma by a Casein Method*

Ulla Hedner
1   Coagulation Laboratory, Department of Medicine, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
,
Inga Marie Nilsson
1   Coagulation Laboratory, Department of Medicine, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Also available at
    Permissions and Reprints

Summary

A modification of the casein method for determination of plasminogen in plasma has been devised.

1. Urokinase instead of streptokinase was used for activation of plasminogen in order to eliminate the effect of any antistreptokinase antibodies in the plasma.

2. A purified and stable plasmin preparation according to Wallén was used for preparing reference curves.

3. The plasminogen activity of plasma was converted into arbitrary casein - olytic units (ACU) defined in such a way that 10 caseinolytic units gave an extinction of 0.300.

4. Removal of the plasmin inhibitors by acidification of plasma to pH 2.0 was found to be better than using euglobulin precipitation.

5. The plasma should be tested immediately after thawing and not allowed to stand after acidification for obtaining optimal conditions.

6. The method can be used for determination of plasminogen in plasma in patients treated with ssss-ACA and AMCA.

7. The error of the method was found to be small ssss0.4.

The mean plasminogen level in a normal group of 72 was found to be 9.5 ssss 1.7 ACU/ml plasma. No variation with sex and age was found.

The method proved clinically useful. During the latter half of pregnancy the plasminogen level was found to be clearly elevated. In patients with liver cirrhosis the plasminogen level was low. It was a sensitive method for following the plasminogen content during streptokinase treatment.

This investigation was supported by grants from the Swedish Medical Research Council, the Medical Faculty of Lund and from the National Institutes of Health, Public Health Service (Research Grant HE 07066).


 

  • References

  • 1 Allcjaersig N, Fletclier A. P, Sherry S. The mechanism of clot dissolution by plasmin. J. clin. Invest. 38: 1086-1095 1959;
    CrossrefPubMedGoogle Scholar
  • 2 Andersson L, Nilsson I. M, Niléhn J. E, Hedner U, Granstrand B, Melander B. Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand. J. Haemat. (In press 1965.
    PubMedGoogle Scholar
  • 3 Blombäck B, Blombäck M, Senning P, Wallen P. Fibrinolysis och fibrinogenolysis som orsak till komplikationer inom kirurgi och obstetrik. Nord. Med. 53: 1019-1024 1955;
    PubMedGoogle Scholar
  • 4 Derechin M. The assay of human plasminogen with casein as substrate. Biochem. J. 78: 443-448 1961;
    CrossrefPubMedGoogle Scholar
  • 5 Fantl P. Plasminogen activity of plasma and serum. Science. 135: 787-788 1962;
    CrossrefPubMedGoogle Scholar
  • 6 Jacobsen G. D. The caseinolytic method for determination of plasminogen plasmin in human plasma and serum. Scand. J. clin. Lab. Invest. 16: 372-382 1964;
    CrossrefPubMedGoogle Scholar
  • 7 Kline D. L. Purification and crystallization of plasminogen (profibrinolysin). J. Biol. Chem. 204: 949-955 1953;
    PubMedGoogle Scholar
  • 8 Kline D. L, Fishman J. B. Plasmin. The humoral protease. Ann. N.Y. Acad. Sci. 68: 25-37 1957;
    CrossrefPubMedGoogle Scholar
  • 9 Kovalski E, Kopec M, Niewiarowski S. An evaluation of the euglobulin method for the determination of fibrinolysis. J. clin. Path. 12: 215-218 1959;
    CrossrefPubMedGoogle Scholar
  • 10 Lassen M. The esterase activity of the fibrinolytic system. Biochem. J. 69: 360-366 1958;
    CrossrefPubMedGoogle Scholar
  • 11 Lassen M. The estimation of fibrinolytic components by means of the lysis time method. Scand. J. clin. Lab. Invest. 10: 384-389 1958;
    CrossrefPubMedGoogle Scholar
  • 12 Macfarlane R. G, Pilling J. Observations on fibrinolysis. Plasminogen, plasmin and antiplasmin content of human blood. Lancet. II: 562-565 1946;
    PubMedGoogle Scholar
  • 13 Markus G, Ambrus C. M. On the formation of different types of plasmin by streptokinase activation. J. biol. Chem. 235: 1673-1679 1960;
    PubMedGoogle Scholar
  • 14 Müllertz S. Formation and properties of the activator of plasminogen and of human and bovin plasmin. Biochem. J. 61: 424-434 1955;
    CrossrefPubMedGoogle Scholar
  • 15 Müllertz S. Mechanism of activation and effect of plasmin in blood. Acta physiol, scand. 38 suppl. 130 1956;
    PubMedGoogle Scholar
  • 16 Müllertz S. Activation of plasminogen. Ann. N.Y. Acad. Sci. 68: 38-51 1957;
    CrossrefPubMedGoogle Scholar
  • 17 Nilsson I. M, Blombäck M, Francken I. v. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand. 159: 35-57 1957;
    PubMedGoogle Scholar
  • 18 Nilsson I. M, Blombäck M, Ramgren O. Hemophilia in Sweden. Coagulation studies. Acta med. scand. 170: 665-682 1961;
    PubMedGoogle Scholar
  • 19 Nilsson I. M, Olow B. Determination of fibrinogen and fibrinogenolytic activity. Thrombos. Diathes. haemorrh. (Stuttg). 08: 297-310 1962;
    PubMedGoogle Scholar
  • 20 Nilsson I. M, Olow B. Fibrinolysis induced by streptokinase in man. Acta chir. scand. 123: 247-266 1962;
    PubMedGoogle Scholar
  • 21 Nilsson I. M, Skanse B, Gydell K. Fibrinolysis in Boeck’s sarcoid. Acta med. scand. 159: 463-470 1957;
    PubMedGoogle Scholar
  • 22 Oncley J. L, Melin M, Richert D. A, Cameron J. W, Gross Jr PM. The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and ßj-lipoprotein into subfractions of human plasma. J. Amer. chem. Soc. 71: 541-550 1949;
    CrossrefPubMedGoogle Scholar
  • 23 Paraskevas M, Nilsson I. M, Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest, lé. 138-144 1962;
    PubMedGoogle Scholar
  • 24 Remmert L. F, Cohen P. Partial purification and properties of a proteolytic enzyme of human serum. J. biol. Chem. 181: 431-448 1949;
    PubMedGoogle Scholar
  • 25 Roberts P. S. Measurement of rate of plasmin action on synthetic substrates. J. biol. Chem. 252: 285-291 1958;
    PubMedGoogle Scholar
  • 26 Sawyer W. D, Alkjaersig N, Fletcher A. P, Sherry S. Studies on the thrombolytic activity of human plasma. J. clin. Invest. 39: 426-434 1960;
    CrossrefPubMedGoogle Scholar
  • 27 Sgouris J. T, Inman J. K, McCall U. B, Andersson H. D. The evaluation of “fibrinolytic” preparations. Vox Sang. 06: 53-59 1961;
    CrossrefPubMedGoogle Scholar
  • 28 Sherry S, Alkjaersig N. Fibrinolytic enzyme of human plasma. Thrombos. Diathes. haemorrh. (Stuttg). 01: 264-288 1957;
    PubMedGoogle Scholar
  • 29 Sherry S, Fletcher A. P, Alkjaersig N. Fibrinolysis and fibrinolytic activity in man. Physiol. Rev. 39: 343-382 1959;
    CrossrefPubMedGoogle Scholar
  • 30 Troll W, Sherry S, Wachman J. Action of plasmin on synthetic substrates. J. biol. Chem. 208: 85-93 1954;
    PubMedGoogle Scholar
  • 31 Wallen P. Studies on the purification of human plasminogen. I. The preparation of a partially purified human plasminogen with a low spontaneous activity. Arkiv Kemi. 19: 451-468 1962;
    PubMedGoogle Scholar
  • 32 Wallén P. Studies on the purification of human plasminogen. II. Further purification of human plasminogen on cellulose ion exchanges and by means of gel filtration through Sephadex. Arkiv Kemi. 19: 469-482 1962;
    PubMedGoogle Scholar
  • 33 Vignal A, Blatrix C. h, Steinbuch M. Fibrinogen free of plasminogen as substrate for fibrinolytic assays. Nature. 193: 693 1962;
    PubMedGoogle Scholar